Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
---|---|---|---|---|---|
Gross Sales | 257.77 | 231.78 | 219.16 | 217.77 | 211.78 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 257.77 | 231.78 | 219.16 | 217.77 | 211.78 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 9.31 | 5.34 | 4.21 | 2.97 | 3.65 |
Total Income | 267.08 | 237.12 | 223.37 | 220.74 | 215.44 |
Total Expenditure | 193.28 | 174.75 | 164.24 | 163.14 | 158.12 |
PBIDT | 73.8 | 62.37 | 59.13 | 57.6 | 57.32 |
Interest | 0.19 | 0.97 | 2.06 | 1.56 | 2.92 |
PBDT | 73.61 | 61.4 | 57.07 | 56.04 | 54.4 |
Depreciation | 14.92 | 12.87 | 16.91 | 15.95 | 11.44 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 14.61 | 13.76 | 11.21 | 10.57 | 13.61 |
Deferred Tax | 2.04 | -3.95 | -1.54 | -1.43 | -1.04 |
Reported Profit After Tax | 42.04 | 38.72 | 30.49 | 30.95 | 30.38 |
Minority Interest After NP | 0 | 0.01 | 0 | 0 | 0 |
Net Profit after Minority Interest | 42.04 | 38.72 | 30.49 | 30.95 | 30.38 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 42.04 | 38.72 | 30.49 | 30.95 | 30.38 |
EPS (Unit Curr.) | 4.36 | 4.37 | 3.57 | 3.59 | 3.54 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 96.35 | 96.35 | 96.35 | 85.85 | 85.85 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 28.63 | 26.9 | 26.98 | 26.44 | 27.06 |
PBDTM(%) | 28.55 | 26.49 | 26.04 | 25.73 | 25.68 |
PATM(%) | 16.3 | 16.7 | 13.91 | 14.21 | 14.34 |
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.